Are Patients with Different Rheumatologic Diseases Under Immunosuppressive Therapies Adequately Screened and Protected Against Viral Hepatitis?
Aim:The aim of this study is to determine the screening rates for hepatitis B (HBV) and C virus (HCV) in patients with rheumatologic diseases who receive immunosuppressive therapies, to evaluate the prevalence of HBV reactivation during the regimens and also to reveal the frequency of vaccination.Ma...
Main Authors: | Gökçe KENAR, Mehmet Nedim TAŞ |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayincilik
2022-06-01
|
Series: | Namık Kemal Tıp Dergisi |
Subjects: | |
Online Access: |
http://namikkemalmedj.com/archives/archive-detail/article-preview/are-patients-with-different-rheumatologic-diseases/52170
|
Similar Items
-
Hepatitis B Virus Reactivation with Immunosuppression: A Hidden Threat?
by: Sama Anvari, et al.
Published: (2024-01-01) -
ELIMINATING VIRAL HEPATITIS : THE INVESTMENT CASE : Report of the WISH Viral Hepatitis Forum 2018 /
by: Pedrana, Alisa, author, et al.
Published: (2018) -
VIRAL HEPATITIS B AND C AS COMORBIDITY IN RHEUMATIC DISEASES: ANALYSIS OF THE DATA OF THE V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY CLINIC OVER 4 YEARS
by: A. E. Karateev, et al.
Published: (2016-07-01) -
A Case of Reactivation of Hepatitis B and Fulminant Hepatitis which developed 3 months following Chemotherapy Including Rituximab in a Patient with Lymphoma
by: Tae Won Lim, et al.
Published: (2014-12-01) -
A study on outcome of hepatic fibrosis in chronic hepatitis B patients on anti-viral therapy
by: Avick Nag, et al.
Published: (2024-02-01)